Laura Wood on Multidisciplinary Collaboration for Managing Immunotherapy Adverse Events

LAURA WOOD, RN, MSN, OCN
Thursday, January 12, 2017
Talk about this article with nurses and others in the oncology community in the General Discussions Oncology Nursing News discussion group.


Laura Wood, RN, MSN, OCN, Cleveland Clinic explains the importance of a multidisciplinary approach when treating patients on immunotherapy.

Patients receiving immunotherapy treatments have autoimmune-type adverse events that are unlike those of chemotherapy. The side effects can be prolonged and require careful monitoring as well as multidisciplinary collaboration. Checking in with gastrointestinal, endocrinology, and other specialists can help to manage and monitor these side effects.

Talk about this article with nurses and others in the oncology community in the General Discussions Oncology Nursing News discussion group.
External Resources

MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc
OncNurse Resources

Blogs
Continuing Education
Discussions
Web Exclusives


About Us
Advertise
Advisory Board
Careers
Contact Us
Privacy Policy
Terms & Conditions
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright OncNursing 2006-2017
Intellisphere, LLC. All Rights Reserved.